Filing Details
- Accession Number:
- 0001127602-12-017205
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-17 13:00:00
- Reporting Period:
- 2012-05-14
- Filing Date:
- 2012-05-17
- Accepted Time:
- 2012-05-17 14:59:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1014739 | Bioscrip Inc. | BIOS | Retail-Drug Stores And Proprietary Stores (5912) | 050489664 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519545 | Patricia Bogusz | 100 Clearbrook Road Elmsford NY 10523 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2012-05-14 | 5,000 | $6.49 | 8,028 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2012-05-14 | 9,000 | $2.47 | 17,028 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.0001 Per Share | Disposition | 2012-05-14 | 14,000 | $7.52 | 3,028 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value | Employee Stock Option | Disposition | 2012-05-14 | 5,000 | $0.00 | 5,000 | $6.49 |
| Common Stock, $.0001 Par Value | Employee Stock Option | Disposition | 2012-05-14 | 9,000 | $0.00 | 9,000 | $2.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-10-24 | 2015-10-24 | No | 4 | M | Direct |
| 0 | 2007-11-01 | 2016-11-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.0001 Par Value | 7,875 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value | Employee Stock Option | $6.52 | 2009-04-29 | 2018-04-29 | 19,687 | 19,687 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $2.73 | 2010-04-28 | 2019-04-28 | 20,000 | 20,000 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $6.46 | 2011-07-27 | 2020-07-27 | 10,000 | 10,000 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $4.24 | 2012-03-01 | 2021-03-01 | 20,000 | 20,000 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $4.42 | 2012-04-26 | 2021-04-26 | 50,000 | 50,000 | Direct |
| Common Stock, $.0001 Par Value | Employee Stock Option | $6.62 | 2013-03-08 | 2022-03-08 | 100,000 | 100,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-04-29 | 19,687 | 19,687 | Direct |
| 2019-04-28 | 20,000 | 20,000 | Direct |
| 2020-07-27 | 10,000 | 10,000 | Direct |
| 2021-03-01 | 20,000 | 20,000 | Direct |
| 2021-04-26 | 50,000 | 50,000 | Direct |
| 2022-03-08 | 100,000 | 100,000 | Direct |
Footnotes
- Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.51 to $7.59 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
- Unvested
Billionaire Hedge Funds
